EPI Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Ending Pricey Insulin Act or the EPI Act
This bill establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin.
Specifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement.
This $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals.
The requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1132: EPI Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-1132/
"S. 1132: EPI Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-1132/.
S. 1132, 117th Cong. (2026), https://openamerica.io/bill/117-S-1132/.
[S. 1132: EPI Act](https://openamerica.io/bill/117-S-1132/)